In addition, in BPC 157 short-bowel rats, the counteraction of the escalating short bowel syndrome provides that all three intestinal wall layers accordingly adapt in parallel with reaching the same weight gain as in normal rats (Sever et al., 2009) (see Fistula Healing as Support )
Tesamorelin: Tesamorelin is a GHRH analog that stimulates natural growth hormone production and has FDA approval for reducing visceral adipose tissue in specific populations
Kornblau SM, Banker DE, Lemker E, Estrov Z, Faderl S, Verstovsek S, Cortes J, Garcia-Manero G, Koller CA, Ravandi-KBlood:ani F, Andreeff M , Jackson CE, Chen W, Petersdorf S, Estey E, Appelbaum FR
59% Increase in total sleep time vs placebo (controlled study) 37 mo Normal sleep maintained after the last dose (chronic insomniacs) 1977 Year DSIP was first isolated 0 Documented dependence or withdrawal in clinical studies Studies show increased delta wave sleep Research on cortisol normalization Trials in chronic pain patients Demonstrated stress-reducing effects What to expect Your DSIP timeline
